Administration of milrinone before ischemia, in the presence of β-blockade, to treat metabolic impairment and myocardial stunning in pigs

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 3, 2008, Pages 397-405

  Sidi, A ^a   Muehlschlegel, J D ^a   Kirby, D S ^b   Lobato, E B ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Coronary occlusion; Esmolol; Ischemia; Milrinone; Phosphodiesterase inhibitor

Indexed keywords

ESMOLOL; LACTIC ACID; MILRINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART OUTPUT; LACTATE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; HEART RATE; LACTIC ACID; MILRINONE; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; PROPANOLAMINES; RANDOM ALLOCATION; SWINE; TIME FACTORS; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38849197776     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01554.x     Document Type: Article

References (24)

1. Haase J, Bayar R, Hackenbroch M et al. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 2004 17 : 367 73.
2. Ellis SG, Henschke CI, Sandor T et al. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1983 1 : 1047 53.
3. Kabela E, Barcenas L, Farah A. Effects of milrinone (Win 47203) on the coronary blood flow and oxygen consumption of the dog heart-lung preparation. Am Heart J 1986 111 : 702 9.
4. 2 or lactate and, by improving myocardial performance, preserves myocardial blood flow in the ischemic canine heart. Anesth Analg 1993 76 : 1201 12.
5. Makela VHM, Kapur PA. Amrinone and verapamil-propranolol induced cardiac depression during isoflurane anesthesia in dogs. Anesthesiology 1987 66 : 792 7.
6. Zausig YA, Stowe DF, Zink W et al. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesth Analg 2006 102 : 1646 52.
7. Felker GM, Benza RL, Chandler AB et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003 41 : 997 1003.
8. Sidi A, Rush W, Davis RF. The influence of esmolol on myocardial metabolism, regional myocardial blood flow, acid-base, and electrolyte balance in dogs after acute coronary ligation. Anesth Analg 1988 67 : 124 30.
9. Mangano DT, Layug EL, Wallace A et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996 335 : 1713 20.
10. Lee KC, Canniff PC, Hamel DW et al. Cardiovascular and renal effects of milrinone in beta-adrenoreceptor blocked and non-blocked anaesthetized dogs. Drugs Exp Clin Res 1991 17 : 145 58.
11. Kim JH, Ham BM, Kim YL et al. Prophylactic milrinone during OPCAB of posterior vessels: implication in angina patients taking β-blockers. Eur J Cardiothorac Surg 2003 24 : 770 6.
12. Kwak YL, Oh YJ, Kim SH et al. Efficacy of pre-emptive milrinone in off-pump coronary artery bypass surgery: comparison between patients with low and normal pre-graft cardiac index. Eur J Cardiothorac Surg 2004 26 : 687 93.
13. Omae T, Kakihana Y, Mastunaga A et al. Haemodynamic changes during off-pump coronary artery bypass anastomosis in patients with coexisting mitral regurgitation: improvement with milrinone. Anesth Analg 2004 101 : 2 8.
14. Davis RF, Sidi A. The effect of isoflurane on the extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood flow, and regional myocardial metabolism in dogs after coronary artery occlusion. Anesth Analg 1989 69 : 575 86.
15. Sidi A, Rush W. Decreased regional lactate production and output due to intracoronary continuous esmolol during acute medium-to-high coronary stenosis. J Cardiothorac Anesth 1991 5 : 237 42.
16. Sidi A, Rush W. Adenosine for controlled hypotension: systemic compared with intracoronary infusion in dogs. Anesth Analg 1992 75 : 319 28.
17. Power JM, Tonkin AM. Large animal models of heart failure. Aust NZ J Med 1999 29 : 395 402.
18. Sidi A, Muehlschlegel JD, Kirby DS et al. Treating ischemic left ventricular dysfunction with hypertonic saline administered following coronary occlusion in pigs. J Cardiothorac Vasc Anesth 2007 21 (3) : 400 5.
19. 2 consumption and lactate production during ischemia in dogs. J Cardiothorac Vasc Anesth 1994 8 (3) : 302 9.
20. Lobato EB, Beaver T, Muehlschlegel J et al. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 2006 96 : 317 22.
21. Sidi A, Muehlschlegel JD, Kirby DS et al. Treating ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. Br J Anaesth 2006 97 : 799 807.
22. Alousi AA, Canter JM, Fort DJ. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetized dog. Cardiovasc Res 1985 19 : 483 95.
23. Lobato EB, Florete O Jr., Bingham HL. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth 1998 81 : 782 4.
24. Janelle GM, Urdaneta F, Blas ML et al. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass. Anesth Analg 2001 92 : 1377 83.